Institutional Ownership
Ernexa Therapeutics Inc
CUSIP 114082308COMQ1 2026
13D / 13G Filings
4
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
34.7%
Max % of class reported
Institutional Holders
18
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
4 filings · latest Feb 17, 2026
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bleichroeder LP | 2.00M | $398.0K |
| 2 | Dauntless Investment Group, LLC | 612.4K | $121.9K |
| 3 | Corient Private Wealth LLC | 438.1K | $87.2K |
| 4 | Geode Capital Management, LLC | 244.4K | $48.6K |
| 5 | Xtx Topco Ltd | 54.3K | $10.8K |
| 6 | Warberg Asset Management LLC | 50.0K | $10.1K |
| 7 | Jane Street Group, LLC | 41.2K | $8.2K |
| 8 | Citadel Advisors LLC | 33.1K | $6.6K |
| 9 | Ubs Group AG | 21.2K | $4.2K |
| 10 | Goldman Sachs Group Inc | 16.6K | $3.3K |